Mustafa AKAR, Sevil Özer SARI, Hüseyin KÖSEOĞLU, Mustafa TAHTACI, Tevfik SOLAKOĞLU, Osman ERSOY, Yunus Halil Polat, Fatma Ebru AKIN

The predictive value of neutrophil-lymphocyte ratio and mean platelet volume in patients with colorectal carcinoma

Aim: This study aimed to investigate neutrophil-lymphocyte ratio (NLR) and mean platelet volume (MPV) for predicting colorectalcancer (CRC).Material and Methods: We investigated retrospectively patients who underwent colonoscopy. The study consisted of 75 patientswith CRC and 91 study participants with normal colonoscopy as control group, and MPV and NLR were compared between groups.MPV and NLR were also investigated for tumor stage and metastasis.Results: Among the CRC patients the mean NLR value (3.09 vs 2.26) and PLT count (287080 vs 251857) were significantly higher,whereas the mean MPV (9.62 vs 10.68 fL) and hemoglobin level (11.62 vs 14.18 g/dl) were significantly lower in the CRC group. WBCcount was not significantly different between the groups. Mean NLR in metastatic patients and non-metastatic patients were 3.56and 2.73, respectively (p:0.01).Conclusion: We showed that high NLR and low MPV are associated with CRC. Elevated NLR is related with presence of CRC and itcan be used for risk prediction. Although we found lower MPV levels, conflicting results about MPV in CRC prevents it from using asa marker in CRC.

PDF

___

1. Jemal A, Bray F, Center MM, et al. Global Cancer Statistics. CA Cancer J Clin 2011;61:69-90.
2. Locker GY, Hamilton S, Harris J, et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 2006;24:5313-27.
3. Palmqvist R, Engarås B, Lindmark G, et al. Prediagnostic levels of carcinoembryonic antigen and CA 242 in colorectal cancer: a matched case-control study. Dis Colon Rectum 2003;46:1538-44.
4. Kai H, Kitadai Y, Kodama M, et al. Involvement of proinflammatory cytokines IL-1beta and IL-6 in progression of human gastric carcinoma. Anticancer Res 2005;25:709-13.
5. Gasparyan AY, Ayvazyan L, Mikhailidis DP, et al.Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des 2011;17:47-58.
6. Kapsoritakis AN, Koukourakis MI, Sfiridaki A, Potamianos SP, Kosmadaki MG, Koutroubakis IE, et al. Mean platelet volume: a useful marker of inflammatory bowel disease activity. Am J Gastroenterol 2001;96:776-81.
7. Yuksel O, Helvaci K, Basar O, et al. An overlooked indicator of disease activity in ulcerative colitis: mean platelet volume. Platelets 2009;20:277-81.
8. Kisacik B, Tufan A, Kalyoncu U, et al. Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis. Joint Bone Spine 2008;75:291-4.
9. Makay B, Turkyilmaz Z, Unsal E. Mean platelet volume in children with familial Mediterranean fever. Clin Rheumatol 2009;28:975-8.
10. Yazici S, Yazici M, Erer B, et al. The platelet indices in patients with rheumatoid arthritis: mean platelet volume reflects disease activity. Platelets 2010;21:122-5.
11. Yazici S, Yazici M, Erer B, , et al. The platelet functions in patients with ankylosing spondylitis: anti-TNFalpha therapy decreases the mean platelet volume and platelet mass. Platelets 2010;21:126-31.
12. Azab B, Jaglall N, Atallah JP, et al. Neutrophillymphocyte ratio as a predictor of adverse outcomes of acute pancreatitis. Pancreatology 2011;11:445-52.
13. Alkhouri N, Morris-Stiff G, Campbell C, et al. Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease. Liver International 2012;32:297-302.
14. Martin JF, Bath PM, Burr ML. Influence of platelet size on outcome after myocardial infarction. Lancet 1991;338:1409-11.
15. O'Malley T, Langhorne P, Elton RA, et al. Platelet size in stroke patients. Stroke 1995;26:995-9.
16. Paramo JA, Rocha E. Deep vein thrombosis and related platelet changes after total hip replacement. Haemostasis 1985;15:389-94.
17. Sen N, Basar N, Maden O, et al. Increased mean platelet volume in patients with slow coronary flow. Platelets 2009;20:23-8.
18. Kurt M, Onal IK, Sayilir AY, et al. The role of mean platelet volume in the diagnosis of hepatocellular carcinoma in patients with chronic liver disease. Hepatogastroenterology 2012;59:1580-2.
19. Karaman K, Bostanci EB, Aksoy E, et al. The predictive value of mean platelet volume in differential diagnosis of nonfunctional pancreatic neuroendocrine tumors from pancreatic adenocarcinomas. Eur J Intern Med 2011;22:95-8.
20. Kilincalp S, Ekiz F, Basar O, et al. Mean platelet volume could be possible biomarker in early diagnosis and monitoring of gastric cancer. Platelets 2014;25:592-4.
21. Perez DR, Baser RE, Cavnar MJ, et al. Blood neutrophilto-lymphocyte ratio is prognostic in gastrointestinal stromal tumor. Ann Surg Oncol 2013;20:593-9.
22. Stotz M, Gerger A, Eisner F, et al. Increased neutrophillymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br J Cancer 2013;109:416-21.
23. Xiao WK, Chen D, Li SQ, et al. Prognostic significance of neutrophil-lymphocyte ratio in hepatocellular carcinoma: a meta-analysis. BMC Cancer 2014;14:117.
24. Chua W, Charles KA, Baracos VE, et al. Neutrophil/ lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer. Br J Cancer 2011;104:1288-95.
25. He W, Yin C, Guo G, et al. Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancer. Med Oncol 2013;30:439.
26. Sharaiha RZ, Halazun KJ, Mirza F, et al. Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer. Ann Surg Oncol 2011;18:3362-9.
27. Shimada H, Takiguchi N, Kainuma O, et al. High preoperative neutrophil–lymphocyte ratio predicts poor survival in patients with gastric cancer. Gastric Cancer 2010;13:170-6.
28. Moiel D, Thompson J. Early detection of colon cancerthe kaiser permanente northwest 30-year history: how do we measure success? Is it the test, the number of tests, the stage, or the percentage of screen-detected patients? Perm J 2011;15:30-8.
29. Espey DK, Wu XC, Swan J, Wiggins C, Jim MA, Ward E, et al. Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. Cancer 2007;110:2119- 52.
30. Xue G, Wang X, Yang Y, et al. Colon cancer-specific antigen-2 may be used as a detecting and prognostic marker in colorectal cancer: a preliminary observation. PLoS One 2014;9:94252.
31. Carpelan-Holmström M, Louhimo J, Stenman UH, et al. CEA, CA 242, CA 19-9, CA 72-4 and hCGbeta in the diagnosis of recurrent colorectal cancer. Tumour Biol 2004;25:228-34.
32. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-7.
33. Toriola AT, Cheng TY, Neuhouser ML, et al. Biomarkers of inflammation are associated with colorectal cancer risk in women but are not suitable as early detection markers. Int J Cancer 2013;132:2648-58.
34. Chan AT, Ogino S, Giovannucci EL, et al.Inflammatory markers are associated with risk of colorectal cancer and chemopreventive response to anti-inflammatory drugs. Gastroenterology 2011;140:799-808.
35. Lee YJ, Lee HR, Nam CM, et al. White blood cell count and the risk of colon cancer. Yonsei Med J 2006;47:646-56.
36. Rothwell PM, Wilson M, Elwin CE, et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 2010;376:1741-50.
37. Li JY, Li Y, Jiang Z, Wang RT, Wang XS. Elevated mean platelet volume is associated with presence of colon cancer. Asian Pac J Cancer Prev 2014;15:10501-4.
38. Inanc M, Duran AO, Karaca H, et al. Haematologic parameters in metastatic colorectal cancer patients treated with capecitabine combination therapy. Asian Pac J Cancer Prev 2014;15:253-6.
39. Goodman D, Irvin TT. Delay in the diagnosis and prognosis of carcinoma of the right colon. Br J Surg 1993;80:1327-9.
40. Macrae FA, St John DJ. Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas. Gastroenterology 1982;82:891-8.